» Articles » PMID: 14504359

Mortality of Employees of a Perfluorooctanesulphonyl Fluoride Manufacturing Facility

Overview
Date 2003 Sep 25
PMID 14504359
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To evaluate the mortality experience of a cohort of employees of a perfluorooctanesulphonyl fluoride (POSF) based fluorochemical production facility.

Methods: A retrospective cohort mortality study followed all workers with at least one year of cumulative employment at the facility. The jobs held by cohort members were assigned to one of three exposure subgroups; high exposed, low exposed, and non-exposed, based on biological monitoring data for perfluorooctane sulphonate (PFOS).

Results: A total of 145 deaths were identified in the 2083 cohort members. Sixty five deaths occurred among workers ever employed in high exposed jobs. The overall mortality rates for the cohort and the exposure subcohorts were lower than expected in the general population. Two deaths from liver cancer were observed in the workers with at least one year of high or low exposure (standardised mortality ratio (SMR) 3.08, 95% CI 0.37 to 11.10). The risk of death from bladder cancer was increased for the entire cohort (three observed, SMR 4.81, 95% CI 0.99 to 14.06). All three bladder cancers occurred among workers who held a high exposure job (SMR 12.77, 95% CI 2.63 to 37.35). The bladder cancer cases primarily worked in non-production jobs, including maintenance and incinerator and wastewater treatment plant operations.

Conclusion: Workers employed in high exposure jobs had an increased number of deaths from bladder cancer; however it is not clear whether these three cases can be attributed to fluorochemical exposure, an unknown bladder carcinogen encountered during the course of maintenance work, and/or non-occupational exposures. With only three observed cases the possibility of a chance finding cannot be ruled out.

Citing Articles

Per- And Poly-Fluoroalkyl Substances (PFAS) Exposure and Risk of Breast, and Female Genital Cancers: A Systematic Review and Meta-Analysis.

Seyyedsalehi M, Maria Kappil E, Zhang S, Zheng T, Boffetta P Med Lav. 2024; 115(6):e2024043.

PMID: 39697081 PMC: 11734636. DOI: 10.23749/mdl.v115i6.16330.


The association between per- and polyfluoroalkyl substances (PFASs) and brain, esophageal, melanomatous skin, prostate, and lung cancer using the 2003-2018 US National Health and Nutrition Examination Survey (NHANES) datasets.

Moon J, Mun Y Heliyon. 2024; 10(2):e24337.

PMID: 38298650 PMC: 10827757. DOI: 10.1016/j.heliyon.2024.e24337.


Case-Cohort Study of the Association between PFAS and Selected Cancers among Participants in the American Cancer Society's Cancer Prevention Study II LifeLink Cohort.

Winquist A, Hodge J, Diver W, Rodriguez J, Troeschel A, Daniel J Environ Health Perspect. 2023; 131(12):127007.

PMID: 38088576 PMC: 10718084. DOI: 10.1289/EHP13174.


Per- and Poly-fluoroalkyl Substances (PFAS) Exposure and Risk of Kidney, Liver, and Testicular Cancers: A Systematic Review and Meta-Analysis.

Seyyedsalehi M, Boffetta P Med Lav. 2023; 114(5):e2023040.

PMID: 37878255 PMC: 10627102.


Exploratory profiles of phenols, parabens, and per- and poly-fluoroalkyl substances among NHANES study participants in association with previous cancer diagnoses.

Cathey A, Nguyen V, Colacino J, Woodruff T, Reynolds P, Aung M J Expo Sci Environ Epidemiol. 2023; 33(5):687-698.

PMID: 37718377 PMC: 10541322. DOI: 10.1038/s41370-023-00601-6.


References
1.
Giesy J, Kannan K . Global distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol. 2001; 35(7):1339-42. DOI: 10.1021/es001834k. View

2.
Olsen G, Burris J, Mandel J, Zobel L . Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees. J Occup Environ Med. 1999; 41(9):799-806. DOI: 10.1097/00043764-199909000-00012. View

3.
Case M, York R, Christian M . Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds. Int J Toxicol. 2001; 20(2):101-9. DOI: 10.1080/10915810151115236. View

4.
Seacat A, Thomford P, Hansen K, Olsen G, Case M, Butenhoff J . Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol Sci. 2002; 68(1):249-64. DOI: 10.1093/toxsci/68.1.249. View

5.
Luebker D, Hansen K, Bass N, Butenhoff J, Seacat A . Interactions of fluorochemicals with rat liver fatty acid-binding protein. Toxicology. 2002; 176(3):175-85. DOI: 10.1016/s0300-483x(02)00081-1. View